Personal information

Activities

Employment (1)

University of California, Riverside: Riverside, California, US

2022-01-01 to present | Postdoctoral fellow (School of Medicine)
Employment
Source: Self-asserted source
Vinicius Canale

Education and qualifications (4)

University of California Riverside: Riverside, CA, US

2017-06 to 2021-12-18 | PhD (Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Vinicius Canale

University of California Riverside: Riverside, CA, US

2014-08 to 2017-05 | Master of Sciences (Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Vinicius Canale

Universidade Estadual de Campinas: Campinas, SP, BR

2012-03 to 2014-05 | Master of Sciences (Pathophysiology)
Education
Source: Self-asserted source
Vinicius Canale

Universidade Paulista: Jundiai, SP, BR

2008-03 to 2012-12 | Bachelor (Biomedicine)
Education
Source: Self-asserted source
Vinicius Canale

Professional activities (2)

American Physiological Society: Bethesda, Maryland, US

2018-12 to present
Membership
Source: Self-asserted source
Vinicius Canale

American Physiological Society: Bethesda, Maryland, US

2023-02-23 | Raj and Prem Goyal Translational Research Award (Gastrointestinal & Liver Section)
Distinction
Source: Self-asserted source
Vinicius Canale

Funding (1)

Implications of mTOR hyperactivity in the glomerular structure of diabetic mice

2014-08 to 2018-08 | Grant
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brasilia, BR)
GRANT_NUMBER:

99999.013456/2013-00

Source: Self-asserted source
Vinicius Canale

Works (8)

PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice

International Journal of Molecular Sciences
2025-04-03 | Journal article
Contributors: Hillmin Lei; Ali Shawki; Alina N. Santos; Vinicius Canale; Salomon Manz; Meli’sa S. Crawford; Pritha Chatterjee; Marianne R. Spalinger; Michael Scharl; Declan F. McCole
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

PTPN2 is a Critical Regulator of Ileal Paneth Cell Viability and Function in Mice

Cellular and Molecular Gastroenterology and Hepatology
2023-04-06 | Journal article
Part of ISSN: 2352-345X
Contributors: Vinicius Canale; Marianne R. Spalinger; Rocio Alvarez; Anica Sayoc-Becerra; Golshid Sanati; Salomon Manz; Pritha Chatterjee; Alina N. Santos; Hillmin Lei; Sharon Jahng et al.
Source: Self-asserted source
Vinicius Canale

PTPN2 regulates bacterial clearance in a mouse model of enteropathogenic and enterohemorrhagic E. coli infection

JCI Insight
2023-02-22 | Journal article
Contributors: Marianne R. Spalinger; Vinicius Canale; Anica Becerra; Ali Shawki; Meli’sa Crawford; Alina N. Santos; Pritha Chatterjee; Jiang Li; Meera G. Nair; Declan F. McCole
Source: check_circle
Crossref

T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling

Journal of Clinical Investigation
2021-09-01 | Journal article
Contributors: Ronald R. Marchelletta; Moorthy Krishnan; Marianne R. Spalinger; Taylaur W. Placone; Rocio Alvarez; Anica Sayoc-Becerra; Vinicius Canale; Ali Shawki; Young Su Park; Lucas H.P. Bernts et al.
Source: check_circle
Crossref

Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence.

Gut
2021-02-09 | Journal article
Source: Self-asserted source
Vinicius Canale

PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function

Gastroenterology
2020-11 | Journal article
Contributors: Marianne R. Spalinger; Anica Sayoc-Becerra; Alina N. Santos; Ali Shawki; Vinicius Canale; Moorthy Krishnan; Anna Niechcial; Nicole Obialo; Michael Scharl; Jiang Li et al.
Source: check_circle
Crossref

The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli

Gut Microbes
2020-11-01 | Journal article
Contributors: Ali Shawki; Rocio Ramirez; Marianne R. Spalinger; Paul M. Ruegger; Anica Sayoc-Becerra; Alina N. Santos; Pritha Chatterjee; Vinicius Canale; Jonathan D. Mitchell; John C. Macbeth et al.
Source: check_circle
Crossref

The JAK inhibitor tofacitinib rescues intestinal barrier defects caused by disrupted epithelial-macrophage interactions.

Journal of Crohn's & colitis
2020-09-10 | Journal article
Source: Self-asserted source
Vinicius Canale